In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Resuscitating a Culture One Beat at a Time

Executive Summary

Its acquisition of privately held Zymed means more to the Healthcare Solutions Group (HSG) of Agilent Technologies than being able to fill a gap in its cardiology business. It is also a part of Agilent's drive to energize its corporate culture following its spin-out of Hewlett-Packard last year. Moreover, in the face of disappointing earnings from HSG and poor near-term growth prospects, Agilent's overall commitment to health care was questioned by Wall Street.


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts